[Clinical results of endolymphatic radionuclide therapy in the treatment of malignant melanoma].
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D001132:Arm; D002648:Child; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D007866:Leg; D008198:Lymph Nodes; D008207:Lymphatic Metastasis; D008220:Lymphography / Q000009:adverse effects; D008297:Male; D008545:Melanoma / Q000473:pathology / Q000532:radiotherapy*; D008875:Middle Aged; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D010761:Phosphorus Radioisotopes / Q000627:therapeutic use; D011379:Prognosis; D011868:Radioisotopes / Q000627:therapeutic use*; D011879:Radiotherapy Dosage; D012878:Skin Neoplasms / Q000473:pathology / Q000532:radiotherapy*
D007457:Iodine Radioisotopes; D009943:Organophosphorus Compounds; D010761:Phosphorus Radioisotopes; D011868:Radioisotopes
Klinische Ergebnisse nach endolymphatischer Radionuklidtherapie bei der Behandlung des malignen Melanoms